300026 红日药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.9350.2475.9607.7739.184
总资产报酬率 ROA (%)0.7370.1874.1375.1456.309
投入资产回报率 ROIC (%)0.8490.2144.8146.0757.469

边际利润分析
销售毛利率 (%)52.18852.75854.10957.72757.933
营业利润率 (%)3.9600.6138.00910.71511.410
息税前利润/营业总收入 (%)3.6461.40610.68211.57711.872
净利润/营业总收入 (%)2.2160.3978.2119.3428.746

收益指标分析
经营活动净收益/利润总额(%)169.487358.05585.741102.181121.848
价值变动净收益/利润总额(%)-2.036-10.429-0.2310.441-2.691
营业外收支净额/利润总额(%)-16.34334.35819.3730.538-2.460

偿债能力分析
流动比率 (X)4.2653.7934.2952.7583.307
速动比率 (X)3.2312.7143.0411.9312.673
资产负债率 (%)18.24421.19625.07233.15431.488
带息债务/全部投入资本 (%)5.7988.13414.77420.58720.041
股东权益/带息债务 (%)1,587.5421,101.805567.423377.808391.990
股东权益/负债合计 (%)440.114365.251293.538197.508212.669
利息保障倍数 (X)15.0432.97414.27714.38316.130

营运能力分析
应收账款周转天数 (天)169.362167.426179.592186.193144.908
存货周转天数 (天)216.681244.461268.047225.278151.834